Evaluation of the safety and effectiveness of prostate-specific antigen (PSA) monitoring in primary care after discharge from hospital-based follow-up following prostate cancer treatment
AffiliationThe Christie NHS Foundation Trust, Manchester,
MetadataShow full item record
AbstractObjective: To examine follow-up procedures after men are discharged into primary care following prostate cancer and highlight any areas for service improvement. Methods: Patient record data from two Greater Manchester boroughs were retrieved retrospectively to investigate discharge instructions and monitoring adherence. Questionnaires were sent to patients exploring their understanding of the follow-up process. Results: A total of 300 records were accessed. Prostate-specific antigen (PSA) re-referral level was provided to GPs in 39% of cases. Forty- six percent of men were not tested frequently enough, and 6% had no PSA testing recorded post-discharge. A total of 222 patient questionnaires were returned. Sixty-seven percent felt GPs should be responsible for PSA monitoring, and 60% felt confident that their GP was doing so effectively. Conversely, 12% felt their PSA monitoring had been neglected. Conclusion: The findings highlight the complex nature of the follow-up and monitoring processes for prostate cancer patients. There is an urgent need for consensus in terms of monitoring frequency and referral pathways. Many patients do not engage in accurate monitoring post-treatment which has implications for early diagnosis of recurrence. Findings will be used to create an evidence-based, uniform Greater Manchester PSA monitoring service which is safe, acceptable and effective for all
CitationJohnson H, Taylor S, Peat S, Booker J, Yorke J. Evaluation of the safety and effectiveness of prostate-specific antigen (PSA) monitoring in primary care after discharge from hospital-based follow-up following prostate cancer treatment. Eur J Cancer Care (Engl). 2020:e13389.
JournalEuropean Journal of Cancer Care
- Initial experience of an algorithm-based protocol for the community follow-up of men with prostate cancer.
- Authors: Goodall PP, Little J, Robinson E, Trimble I, Cole OJ, Walton TJ
- Issue date: 2017 Jan
- Evaluating the use of prostate-specific antigen as an instrument for early detection of prostate cancer beyond urologists: results of a representative cross-sectional questionnaire study of general practitioners and internal specialists.
- Authors: Gilfrich C, May M, Braun KP, Lebentrau S, Lehsnau M, Ecke T, Schmailzl KJ, Al-Dumaini S, Hallmann S, Ahmed AM, Maurer J, Karl T, Braun V, Haferkamp A, Brookman-May S, Bauer RM, Stief CG, Hoschke B, Maurer O, Wolff I
- Issue date: 2014
- Prostate-specific antigen testing in general practice: a survey among 325 general practitioners in Denmark.
- Authors: Jønler M, Eddy B, Poulsen J
- Issue date: 2005
- Multivariable risk-based patient selection for prostate biopsy in a primary health care setting: referral rate and biopsy results from a urology outpatient clinic.
- Authors: Osses DF, Alberts AR, Bausch GCF, Roobol MJ
- Issue date: 2018 Feb
- GPs views and understanding of PSA testing, screening and early detection; survey.
- Authors: Sutton J, Melia J, Kirby M, Graffy J, Moss S
- Issue date: 2016 May